Market Overview
Market Research Future (MRFR) says that the global gene expression analysis market could hold the value of USD 3.250 million by 2023. The market could also achieve a CAGR of 9.1% during the forecast period (2018-2023).
Growth Boosters and Key Restraints
Personalized medicine, with its ability to affect diagnostic and treatment decisions for every patient, has brought an evolution in modern medicine. Diagnosis, treatment, as well as lifestyle interventions, have now become progressively personalized to every patient genetics, family history along with other factors.
Technologies have made it easier for healthcare professionals to track every patient’s health information and offer personalized care. Personalized medicine has gained immense traction as a result of the boost in the number of genetic disorders. Additionally, the mounting awareness about this form of treatment will drive the market in the near future. The rising technological advancement including molecular services and NGS are uplifting the demand for gene expression services. This factor will ensure the success of the gene expression analysis market analysis during the evaluation period.
The downside could be the high cost of instruments, hindering the market growth in the review period. But the development of genomic databases, surge in government funding towards genomics, and increasing personalized medicine are projected to elevate the market position in the subsequent years.
Rising Investments in Gene Expression Analysis Researches
With single cell gene expression, genetic modifications recorded in animals like mice has given way to advancements in drug discover as well as development, clinical diagnostics and biotechnology, among others. Companies along with research institutes are working on projects based on gene expression analysis. These projects are seeing massive success backed by high investments as the demand for nucleic acid analysis, gene cloning & analysis, and other related microbiological methods is rising.
Leading Vendors
Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Pacific Biosciences of California, Inc., Illumina, Inc., Genotypic Technology Pvt Ltd, Danaher, QIAGEN, Oxford Gene Technology, Thermo Fisher Scientific, BGI, PerkinElmer Inc., Macrogen Inc., Eurofins Scientific, are some of the companies currently leading the worldwide gene expression analysis market.
Market Segmentation
The global market for epigenetics drugs has been segmented on the basis of product, services, application, and end-user.
The market, product-wise, include consumables and instruments.
Depending on consumables, the market covers reagents and DNA chips.
Instruments-based segments in the market are polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and others.
The services mentioned in the report are gene expression profiling services, sequencing services, bioinformatics solutions, and others.
Gene expression analysis finds applications in drug discovery, diagnosis, research, and others.
The end-users highlighted in the report are pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.
Regional Outlook
The primary markets for gene expression analysis are Europe, Asia Pacific, Middle East & Africa and the Americas.
During the forecast period, the Americas could very well reach the top position in the global gene expression analysis market, estimates MRFR. The highly-established infrastructure, huge expenditure, and increasing research and development activities in the region play a big role in this growth. The market also gets a boost from the large number of established players based in the region. Case in point is GE Healthcare, which alone generated revenue of USD 19.1 Billion in 2017.
Standing at the second spot, Europe is now an established region in the global gene expression analysis market. The regional market gains from the numerous government initiatives taken in research and development associated with gene expression analysis. Europe is also inundated with esteemed companies such as F. Hoffmann-La Roche Ltd. To illustrate, F. Hoffmann-La Roche, in February 2018, had received an approval from the U.S. Food and Drug Administration (FDA) for its multiplex Factor V and Factor II assessment which could be used on Cobas 4800 systems. This system is known for achieving real-time PCR analysis for high volume labs.
Asia Pacific could expect the fastest growth in the worldwide market. The rising number of global partnerships for the expansion of the region’s healthcare sector, government focus on cancer as well as life science research and internal manufacturing of the sequencing systems favors the regional market. Other factors promoting market growth could be the massive R&D investments and the booming bioresearch centers. On top of this, the surge in the number of research activities in agriculture and the growing approval of gene expression tests add to the market’s strength.
Middle East and Africa could project weak growth in the coming years on account of substandard healthcare amenities and low fund investments associated with research and development activities.
Industry Update
Amicus Therapeutics Inc. has collaborated with Thermo Fisher Scientific, wherein the process for CLN6 Batten disease gene therapy will now be moved to Thermo Fisher. It will now go through a similar GMP process for commercial and clinical level manufacturing as well as supply.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The major factors driving the growth of the gene expression analysis market include decreasing cost of sequencing, rising prevalence of cancer, growing application areas of genomics, and the availability of gene expression databases.The report Gene Expression Analysis Market is expected to reach USD 4.9 billion by 2023 from USD 3.2 billion in 2018, at a CAGR of 8.8%.Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156613968Market Segmentation:- On the basis of products and services, the global Gene Expression Analysis Industry has been segmented into consumables (reagents, DNA chips), Instruments (PCR, NGS, Microarray, others), and services (gene expression profiling services, bioinformatics solutions).
The consumables segment is estimated to command the largest share of the market in 2018 and is also projected to register the highest CAGR.Based on end user, the market has been segmented into pharmaceutical and biotechnology companies, academic institutes and research centers, and other end users.
The pharmaceutical and biotechnology companies segment is expected to command the largest share of 54.8% of the market in 2018.Recent DevelopmentsIn January 2017, Biorad acquired of RainDance Technologies, a droplet-based PCR systems manufacturer.
RainDance Technologies has a more focused portfolio, primarily known for its droplet-based technologies for digital PCR (dPCR).In March 2016, Thermo Fisher Scientific completes acquisition of Affymetrix, a leading provider of cellular and genetic analysis products.Regional Analysis:-Geographically, North America is expected to dominate the global gene expression analysis market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period.Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=156613968Top Key Players:-The major players operating in the Gene Expression Analysis Industry include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Bio-Rad Laboratories, Inc. (US) are the key players in the gene expression analysis market.
It is an indicator of biological activity of changing gene expression pattern, this is a widely used the approach in research, clinical and pharmaceutical to understand individual gene.
It is the study of gene products by imaging, amplification, probe hybridization or sequencing-based detection methods.
With the help of gene expression, the genetic code on a DNA can be studied.
Latest released the research study on Global Gene expression analysis Market, offers a detailed overview of the factors influencing the global business scope.
Gene expression analysis Market Data Breakdown and Market Segmentation: by Type (Consumables (Reagents, DNA Chips), Instruments (PCR, NGS, Microarray)), Application (Diagnostics, Pharmacogenomics, Toxicology, Compare Expression Levels of One or More Genes from Biomarkers), Techniques Types (Absolute Quantitation Techniques (Serial Analysis of Gene Expression), Microarrays), Service Types (Gene Expression Profiling Services, Bioinformatics Solutions) What's Trending in Market:Real-Time PCR Has Risen As the Most Popularly Used Approach in StudiesChallenges:Lack of Skilled Labor Is Become Hurdle For Innovations in FirmRestraints:High Cost of Instrument Will Lead To Decline the MarketMarket Growth Drivers:Decreasing Cost of SequencingHigh Availability of Gene Expression DatabasesGrowing Application Areas of Genomics Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & AfricaCountry Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
– Latest industry influencing trends and development scenario – Open up New Markets – To Seize powerful market opportunities – Key decision in planning and to further expand market share – Identify Key Business Segments, Market proposition & Gap Analysis – Assisting in allocating marketing investments Strategic Points Covered in Table of Content of Global Gene expression analysis Market:Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Market Keyword without Region marketChapter 2: Exclusive Summary – the basic information of the Gene expression analysis Market.Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Gene expression analysisChapter 4: Presenting the Gene expression analysis Market Factor Analysis, Post COVID Impact Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020Chapter 6: Evaluating the leading manufacturers of the Gene expression analysis market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company ProfileChapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2026)Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Finally, Gene expression analysis Market is a valuable source of guidance for individuals and companies in their decision framework.
Global Gene Expression Analysis Market is valued at USD 3219.8 Million in 2018 and expected to reach USD 5889.6 Million by 2025 with the CAGR of 9.01% over the forecast period.Increasing adoption of targeted molecular therapy for the treatment of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders as well as the growing demand for personalized medicines with rising geriatric populations are some of the major factors driving the growth of Global Gene Expression Analysis Market.Scope of Global Gene Expression Analysis Market Report–Gene expression analysis is a process of providing the valuable insight identification and verification of biomarker signature in normal biological and disease.
The research generates the information about the changes of molecular function in phenotype, intracellular localization and other changes that have caused the disease.
In addition to this, the researcher from National Center for Geriatrics and Gerontology has found that genes change connections between proteins, called protein domain networks (PDNs), are being significantly associated with neurodegeneration in Alzheimer's disease.Get Sample of This Report@ https://industrystatsreport.com/Request/Sample?ResearchPostId=12814=Sample Key players for Global Gene Expression Analysis Market Report–Global Gene expression analysis market reports cover prominent players like F. Hoffmann-La Roche, Agilent Technologies, BGI, Bio-Rad Laboratories Inc., Pacific Biosciences, Eurofins Scientific, GE Healthcare, Illumina, Inc., Oxford Gene Technology, Perkinelmer Inc., Qiagen N.V., Thermo Fisher Scientific and others.The global gene expression analysis market is segmented on the basis of product type, services, end-user and region & country level.
On the basis of end-user, the market is segmented into pharmaceutical and biotech companies, academic institutes and research centers and others.The regions covered in global gene expression analysis market report are North America, Europe, Asia-Pacific and Rest of the World.
On the basis of country level, Global gene expression analysis market sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.Global Gene Expression Analysis Market Dynamics–The key factor for growth of global gene expression analysis market is increasing adoption of targeted molecular therapy for treatment of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders as well as the growing demand for personalized medicines with rising geriatric populations.
For example, according to Federation of Indian Chambers of Commerce & Industry (FICCI), India has shortage of nearly 80% of Doctorate, production staff shortage of 18% in the biotechnology sector and post doctorate scientists, a 20% shortage of people with a master’s degree.
Gene Expression Analysis Market Research Report: Information by Product (Consumables & Instruments), Service (Gene Expression Profiling & Others), Application (Drug Discovery & Others), End User (Academic, Research Institutes & Others) - Forecast till 2027As per Market Research Future (MRFR) analysis, the global gene expression analysis market is estimated to hold a market value of USD 3.250 million with a CAGR 9.1% from 2018 to 2023 (forecast period).
Synthesizing functional gene products like functional RNAs and protein species provides insights into how an intact organism survives when a particular gene is missing.Market DynamicsPersonalized medicine is becoming more popular, with an increasing number of genetic disorders.
In addition, increasing awareness of personalized medicine is expected to drive growth over the forecast period.
Moreover, the advancement of genomic databases increased government support for genomics, and growth in personalized medicine is likely to drive the market.
However, the shortage of skilled labor and the high cost of instruments may inhibit market growth during the forecast period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7805 Market SegmentationThe global market for gene expression analysis has been segmented into product, consumables, instruments, services, application, and end-user.Based on the product, the global market for gene expression analysis has been segmented into consumables and instruments.Based on consumables, the global market for gene expression analysis has been further segmented into reagents and DNA chips.Based on instruments, the global market for gene expression analysis has been further segmented into next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, Sanger sequencing, and others.Based on services, the global market for gene expression analysis segmented into gene expression profiling services, sequencing services, bioinformatics solutions, and others.Based on the application, the global market for gene expression analysis has been segmented into drug discovery, diagnosis, research, and others.Based on end-user, the global market for gene expression analysis has been segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and others.Regional AnalysisRegionally, the global market for gene expression analysis has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.The Americas are predicted to dominate the global market for gene expression analysis due to increasing research activities and the increasing popularity of gene expression tests.
In addition, the well-developed healthcare sector is predicted to improve the American market for gene expression analysis.Europe is predicted to hold the second-largest position in the global market for gene expression analysis.
19 February 2020 - The global Gene Expression Market is estimated to reach USD 11.3 billion by 2025.
Market is also expected to grow at a decent rate over the forecast period driven by rising number of cancer patients, facilities for financial funding, decreased cost of sequencing, and high concentration on research & development.
In emerging economies, the industry offers advantageous opportunities for growth with rising concentration on adoption and precision as well as personalization in medicines.
However, currency devaluation in developing economies and initial capital investment of different instruments are considered as restraint as well as challenge for the industry.The gene expression is a set of steps for a functional genetic code product occur in the synthesis, with the support of the data coded on genes.
The process is prominent in multi cellular organisms as well as bacteria such as eukaryotes or prokaryotes, which ensure the creation of machinery macro molecular of their life.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/gene-expression-analysis-marketIn context with the consumables of gene expressions, the industry is classified into DNA chips and reagents.
Aforementioned factor would drive the demand for profiling services over the forecast period.The genetic code expression includes translation and transcription process.
